Results 11 to 20 of about 7,212 (251)

Depo Medroxyprogesterone Acetate (DMPA): Long-Term Effects on Menstrual Cycle Disorders

Indonesian Journal of Obstetrics and Gynecology, 2023
bjective: To determine the effect of the duration of using Depo Medroxyprogesterone Acetate (DMPA) on the Menstrual Cycle. Methods: This research is an analytical study of 102 patients who used DMPA for less than 1 year and more than 1 year and then ...
Nurhayati Nurhayati, Suhermi S, Sitti H. Hamang   +2 more
doaj   +3 more sources

GANGGUAN MENSTRUASI PADA AKSEPTOR DMPA TIDAK TERKAIT IMT [PDF]

Indonesian Midwifery and Health Sciences Journal, 2021
Abstrak  Latar Belakang: Kejadian akseptor drop out tertinggi karena efek samping yaitu pada metode suntikan. KB injeksi DMPA memiliki efek samping gangguan menstruasi. Untuk menjamin lancarnya menstruasi, wanita harus mempunyai kadar lemak sebanyak 22%
Cicilia Valentine Simamora, Sri Ratna Dwiningsih, Ninik Darsini   +2 more
doaj   +2 more sources

HUBUNGAN LAMA PENGGUNAAN KONTRASEPSI DEPO MEDROKSIPROGESTERON ASETAT (DMPA) DENGAN OBESITAS

Averrous: Jurnal Kedokteran dan Kesehatan Malikussaleh, 2018
Penelitian ini bertujuan untuk mengetahui hubungan lama penggunaan kontrasepsi DMPA dengan obesitas. Penelitian dilakukan dengan menggunakan metode analitik cross sectional  terhadap 78 responden.
Suciana Suciana, Rajuddin Rajuddin, Azhari Gani   +2 more
doaj   +3 more sources

DMPA injectable use: Findings from the 21-month DMPA monitoring study

, 1996
This report presents the results of the DMPA Monitoring Study undertaken by the Population Council, Manila, as a technical assistance project for the DMPA Reintroduction Program of the Department of Health.
Population Council
core   +2 more sources

Experience with the DMPA injectable contraceptive: Findings from a survey of DMPA acceptors

, 1995
This report presents the results of a survey of 899 DMPA acceptors who availed of injectable contraceptive services from public health facilities under the Philippine Department of Health\u27s (DOH) DMPA Reintroduction Program.
Costello, Marilou P., Patron, Maria Carmela   +1 more
core   +2 more sources

Efektivitas Pil Oral Kombinasi Dosis Rendah dalam Pengelolaan Perdarahan Uterus Abnormal pada akseptor DMPA [PDF]

Obgynia, 2019
Objective: To explore the effectivity of Low Dose Oral Contraceptive Pills (LDOCP) in managing AUB in DMPA users. Method: We performed the study to investigate the effect of LDOCP in managing AUB in DMPA users. This study was performed in Dr.
Rabiah Adawiyah, Inu Mulyantoro
doaj   +2 more sources

1,25 dihydroxyvitamin D dan kalsium pada akseptor depot medroxyprogesteron asetat (DMPA) berdasarkan lama pemakaian

Jurnal Gizi Klinik Indonesia, 2018
Background: Long – term usage of depot medroxyprogesterone acetate (DMPA) may suppress estrogen levels causing the body to undergo hypoestrogenic. The hormone estrogen affects the metabolism of calcium and 1,25 dihydroxy vitamin D in the body.
Netti Meilani Simanjuntak, Eti Yerizel, Yusrawati Yusrawati   +2 more
doaj   +3 more sources

Serum Vascular Endothelial Growth Factor (VEGF) in DMPA Acceptors: Influence on Bleeding Occurrence

Indonesian Journal of Obstetrics and Gynecology, 2015
Objective: To analyze the relationship between levels of serum vascular endothelial growth factor (VEGF) and bleeding occurrence in depo medroxyprogesterone acetate (DMPA) acceptors.
Ratih Pratiwi, Rizani Amran, Usman Said, Irsan Saleh   +3 more
doaj   +3 more sources

KEJADIAN AMENORE SEKUNDER PADA AKSEPTOR SUNTIK DMPA

MIKIA: Mimbar Ilmiah Kesehatan Ibu dan Anak (Maternal and Neonatal Health Journal), 2017
Depo Medroxyprogesterone Acetate (DMPA) is one of the most commonly used types of injectable contraceptives that have side effects of menstrual disorders. The duration of DMPA contraception is thought to be the cause of secondary amenorrhoea. Research Iswandiyah (2015) showed that most (81.8%) who used the injection for more than 1 year experienced ...
Nurya Viandika, Nurfitria Dara Latuconsina   +1 more
openalex   +3 more sources

Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model

Viruses, 2022
Contraceptives such as Depo-medroxyprogesterone (DMPA) are used by an estimated 34 million women worldwide. DMPA has been associated with increased risk of several viral infections including Herpes simplex virus-2 (HSV-2) and Human immunodeficiency virus
Jiafen Hu, Sarah A Brendle, Vonn Walter   +2 more
exaly   +3 more sources